Hollon, SD, Munoz, RF, Barlow, DH, Beardslee, WR, Bell, CC, Bernal, G, et al. Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and increasing access. Biol Psychiatry
2002; 52: 610–30.
Judd, LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry
1997; 54: 989–91.
Scott, J. Depression should be managed like a chronic disease. BMJ
2006; 332: 985–6.
Fava, GA. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med
1999; 29: 47–61.
Judd, LL, Paulus, MP, Zeller, P, Fava, GA, Rafanelli, C, Grandi, S, et al. The role of residual subthreshold depressive symptoms in early episode relapse in unipolar depressive disorder. Arch Gen Psychiatry
1999; 56: 764–5.
Paykel, ES, Ramana, R, Cooper, Z, Hayhurst, H, Kerr, J, Barocka, A. Residual symptoms after partial remission – an important outcome in depression. Psychol Med
1995; 25: 1171–80.
Scott, J. Partial remission in depressive disorders. Acta Psychiatr Scand
1997; 95: 265–71.
Fava, GA, Grandi, S, Zielezny, M, Canestrari, R, Morphy, MA. Cognitive-behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry
1994; 151: 1295–9.
Fava, GA, Rafanelli, C, Grandi, S, Canestrari, R, Morphy, MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry
1998; 155: 1443–5.
Paykel, ES, Scott, J, Teasdale, JD, Johnson, AL, Garland, A, Moore, R, et al. Prevention of relapse in residual depression by cognitive therapy – a controlled trial. Arch Gen Psychiatry
1999; 56: 829–35.
Paykel, ES, Scott, J, Cornwall, PL, Abbott, R, Crane, C, Pope, M, et al. Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med
2005; 35: 59–68.
Kocsis, JH, Gelenberg, AJ, Rothbaum, BO, Klein, DN, Trivedi, MH, Manber, R, et al. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression. Arch Gen Psychiatry
2009; 66: 1178–88.
Watkins, ER, Scott, J, Wingrove, J, Rimes, KA, Bathurst, N, Steiner, H, et al. Rumination-focused cognitive behaviour therapy for residual depression: a case series. Behav Res Ther
2007; 45: 2144–54.
Watkins, ER. Depressive rumination: investigating mechanisms to improve cognitive-behavioral treatments. Cogn Behav Ther
2009; 38: 8–14.
Nolen-Hoeksema, S. Responses to depression and their effects on the duration of depressive episodes. J Abnorm Psychol
1991; 100: 569–82.
Watkins, ER. Constructive and unconstructive repetitive thought. Psychol Bull
2008; 134: 163–206.
Riso, LP, du Toit, PL, Blandino, JA, Penna, S, Dacey, S, Duin, JS, et al. Cognitive aspects of chronic depression. J Abnorm Psychol
2003; 112: 72–80.
Roberts, JE, Gilboa, E, Gotlib, IH. Ruminative response style and vulnerability to episodes of dysphoria: gender, neuroticism, and episode duration. Cognit Ther Res
1998; 22: 401–23.
Ciesla, JA, Roberts, JE. Self-directed thought and response to treatment for depression: a preliminary investigation. J Cogn Psychother
2002; 16: 435–53.
Schmaling, KB, Dimidjian, S, Katon, W, Sullivan, M. Response styles among patients with minor depression and dysthymia in primary care. J Abnorm Psychol
2002; 111: 350–6.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 12: 52–62.
Beck, AT, Steer, RA, Brown, GK. The Beck Depression Inventory (2nd edn). The Psychological Corporation, 1996.
British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary (issue 60). BMJ Group and Pharm Press, 2010.
Williams, JBW. A structured clinical interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry
1998; 45: 742–7.
Spitzer, RL, Williams, JBW, Gibbon, M, First, MB. Structured Clinical Interview for DSM-IV (SCID). American Psychiatric Association, 1996.
Nolen-Hoeksema, S, Morrow, J. A prospective-study of depression and posttraumatic stress symptoms after a natural disaster – the 1989 Loma-Prieta Earthquake. J Pers Soc Psychol
1991; 61: 115–21.
Jacobson, NS, Martell, CR, Dimidjian, S. Behavioral activation treatment for depression: returning to contextual roots. Clin Psychol
2001; 8: 255–70.
Schulz, K, Altman, DG, Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med
2010; 152: 1–6.
Baron, RM, Kenny, DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol
1996; 51: 1173–82.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol
2006; 74: 658–70.
Ehring, T, Watkins, ER. Repetitive negative thinking as a transdiagnostic process. Int J Cogn Ther
2008; 1: 192–205.
Harvey, AG, Watkins, E, Mansell, W, Shafran, R. Cognitive Behavioural Processes Across Psychological Disorders. Oxford University Press, 2004.
Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry
2002; 59: 877–83.
Emsley, R, Dunn, G, White, I. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res
2010; 19: 237–70.